UBS Maintains Buy on Labcorp Holdings, Raises Price Target to $380

Benzinga Newsdesk www.benzinga.com Positive 79.7%

Neg 0% Neu 0% Pos 79.7%

UBS analyst Kevin Caliendo maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $361 to $380.